Collectively, our findings demonstrate that LTN not only directly potentiates CAR-T cell anti-tumor activity but also reprograms TAMs toward an immunostimulatory state, thereby augmenting overall anti-tumor immunity. The gene discussed is XCL1; the disease is neoplasm.